Victoria Gray was the first patient in the U.S. with sickle cell disease to be treated with CRISPR technology.

The personalized CRISPR-based gene therapy administered to Baby KJ cost approximately $800,000.

An executive from OpenAI suggested that the company should receive a share of sales from drug discoveries made using its ChatGPT platform.